Clinical trial Recruiting at 1 site Observational Ages 35 and up

Genetic factors in early-onset dementia

Official title: Genetic Studies of Early-onset Dementia

Run by Columbia University · NCT04906863 · Data updated 2026-11-12

This study is trying to find out how genetics might affect the risk and progression of early-onset dementia by looking at people with dementia, their families, and healthy individuals.

Quick facts

Study typeObservational
Ages35 Years and up
SexAll
Enrollment1000 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedSeptember 14, 2016
Main results expectedApril 30, 2028
Study endsApril 30, 2028
Registry record updatedApril 29, 2026
Trial IDNCT04906863 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 and older diagnosed with early-onset dementia, their family members, and unrelated healthy controls without dementia.

Probably not a fit

Patients with competing diagnoses such as Huntington's disease, traumatic brain injury, or schizophrenia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify genetic factors that contribute to the risk and progression of early-onset dementia, including Alzheimer's Disease and mild cognitive impairment. It involves individuals diagnosed with dementia, their family members, and cognitively healthy controls. Participants will undergo blood draws, neurocognitive testing, and complete medical questionnaires to gather comprehensive data across diverse ethnic groups. The study seeks to enhance understanding of the genetic underpinnings of early-onset dementia.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding of genetic risks for early-onset dementia, potentially guiding prevention and treatment strategies.

How similar studies have gone: Other studies have shown success in identifying genetic factors related to dementia, making this approach both relevant and promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* 35 years and older
* Individuals experiencing memory concerns or diagnosed with dementia and their family members that are unrelated healthy controls without dementia.

Exclusion Criteria:

\- Individuals with competing diagnosis such as Huntington's disease, traumatic brain injury, drug or alcohol abuse, or schizophrenia, etc., unless family members of a dementia affected individual

Where it's running

  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.